# Good Start Genetics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/good-start-genetics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.goodstartgenetics.com
- Total disclosed funding: $32M
- Latest round: Series B (Apr 2, 2012)
- Investors on record: 3

## About

Good Start Genetics, Inc. offers advanced genetic testing solutions that enhance reproductive and prenatal health, assisting individuals and couples in making informed reproductive choices through comprehensive genetic screening services.Good Start Genetics, Inc. specializes in genetic testing for reproductive health and was founded in 2008 in Cambridge, US. The company was acquired by Invitae Corporation for USD 24.3 mn in July 2017. The founder’s prior history is not specified, and no subsidiaries or parent companies are mentioned. Good Start Genetics has completed a total of 7 deals, with the latest funding round being the Add-on Trade Sale resulting in a total amount raised of USD 14.00 mn.Good Start Genetics specializes in advanced genetic testing solutions aimed at enhancing reproductive and prenatal health. The company provides comprehensive genetic screening services that assist individuals and couples in making informed reproductive choices, including tests that inform about carrier status for various genetic conditions. Their services are utilized primarily by expectant parents, fertility clinics, and healthcare providers across the United States, focusing on areas that prioritize advanced reproductive technologies and genetic health awareness.Good Start Genetics generates revenue through direct-to-consumer and B2B transactions, with a business model that integrates genetic testing services into standard reproductive health protocols via partnerships with healthcare providers and fertility clinics. Revenue is derived from the sale of individual tests and screening services, with clients paying for specific panels based on health needs and genetic backgrounds, supporting long-term relationships with providers and creating a recurring revenue stream.The company aims to expand its product offerings and enhance service delivery by developing new genetic testing panels tailored to emerging health needs, with planned releases expected within the next year. Additionally, Good Start Genetics is targeting expansion into new geographic regions, particularly areas with growing awareness of genetic health, by mid-2024. The recent funding from the acquisition by Invitae Corporation will be utilized to support these initiatives, ensuring the company can enhance its technological capabilities and broaden market reach.

## Funding rounds

- Series B, Apr 2, 2012, $14M — OrbiMed Advisors, Safeguard Scientifics, SV Health Investors
- Series A, Sep 2, 2010, $18M — OrbiMed Advisors, Safeguard Scientifics, SV Health Investors

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B